Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised MicePeter Cuthbertson, Ronald Sluyter, Amy Button et al.|International Journal of Molecular Sciences|2024Cited by 5
Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised miceChloe Sligar, Debbie Watson, Katrina M. Bird et al.|Clinical & Translational Immunology|2024Cited by 5